You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A rapid and high-throughput microfluidic stem cell analyzer
SBC: CFD RESEARCH CORPORATION Topic: OSD11H14Current methods to discern the differentiation state of stem cells are time-consuming, labor-intensive, costly, invasive, and consequently, ill-suited for clinical applications. To overcome these limitations, we propose to develop a microfluidic stem cell analyzer for accurate, non-invasive identification of the cell differentiation state in conjunction with automated cell sorting at high-throughp ...
SBIR Phase II 2013 Department of DefenseDefense Health Agency -
Development of a field-appropriate biosensor for detecting Mycobacterium tuberculosis infection
SBC: NANORETE, INC. Topic: OSD11H05nanoRETE is a developing a nanoparticle-based biosensor technology platform that has the ability for real-time detection of pathogens. Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis (Mtb) that primarily affects the lungs. In Phase I research, nanoRETE demonstrated proof-of-concept of an electrochemical nano-bead biosensor for measuring plasma cytokine and chemokine concentrati ...
SBIR Phase II 2013 Department of DefenseDefense Health Agency -
An automated, high throughput, resin-free device for large scale protein purification
SBC: CFD RESEARCH CORPORATION Topic: CBD12102Protein manufacturing is of paramount importance to chemical and biological defense applications. High-throughput protein purification is a critical need for rapidly scaling the target protein product. Existing purification methods primarly rely on synthetic-resin based chromatography, which is time-consuming, labor-intensive, expensive, and consequently, ill-suited for developing rapid countermea ...
SBIR Phase I 2013 Department of DefenseOffice for Chemical and Biological Defense -
A Novel, Aerodynamics-augmented Continuous Ionization System for Electrostatic Collection of Bioaerosols
SBC: CFD RESEARCH CORPORATION Topic: CBD12107Safe and efficient air ionization and filtration technology compatible to biodefense applications is of paramount importance. Current ionization methods are energy-intensive, costly, prone to ozone generation, or inefficient, and consequently ill-suited for building protection applications. To overcome these issues, we propose to develop and demonstrate a novel bioaerosol ionization and collection ...
SBIR Phase I 2013 Department of DefenseOffice for Chemical and Biological Defense -
CBRN Sensor and Sensor Netting Algorithms
SBC: Torch Technologies, Inc. Topic: CBD09110information) During Phase I the Torch Technologies developed, demonstrated, and assessed the feasibility of an innovative, real-time multi-layered CW sensor data fusion network capability supporting advanced standoff detection and early warning against CB threats. Torch merged two significant technologies that we developed for the Department of Defense: 1) the ACRES CW multi-sensor data fusion t ...
SBIR Phase II 2010 Department of DefenseOffice for Chemical and Biological Defense -
A Novel Microfludic Device for Drug Toxicity Studies
SBC: CFD RESEARCH CORPORATION Topic: CBD10103Current drug discovery and development programs are severely limited by the expensive animal trials and oversimplified in vitro models. Results obtained from the in vitro models are not predictive of in vivo toxicity owing to significant difference in testing from the in vivo physiological conditions. In this context, we propose to develop and demonstrate a novel microfluidic device for quantitati ...
SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense -
Microfluidic High-throughput Platform for Determining of Kinetic Constants of Enzyme Variants
SBC: CFD RESEARCH CORPORATION Topic: CBD10107Molecular biology techniques allow generating combinatorial libraries of large number of enzyme variants. However, there is currently no technology available for screening the enzyme libraries for identifying variants with improved activity for the substrate. We propose to develop a novel, microfluidic, high-throughput platform for determining kinetic constants of enzyme variants and identifying v ...
SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense -
Novel MicroPower Source for Insect Based Sensor and Communication Platforms
SBC: CFD RESEARCH CORPORATION Topic: CBD09105Our objective is to develop a novel micropower source to be integrated with a microsensor, and communication chip on an insect, delivering a state-of-the-art unmanned chemical detection device. The biological fuel cell (Bio-FC) power source will leverage ongoing research at CFDRC and provide a compact/lightweight power supply for mounting on numerous types of insects and producing necessary power ...
SBIR Phase II 2010 Department of DefenseOffice for Chemical and Biological Defense -
AC Impedance Sensor for Collective Protection Filter Residual Life Indicator
SBC: GUILD ASSOCIATES INC Topic: CBD10106Guild Associates, Inc. proposes to develop and evaluate an active electrochemical sensor based residual life indicator (RLI) for adsorptive carbon filters. The sensing system of the RLI will operate by analyzing the electrochemical state of the carbon within the filter and evaluate the remaining adsorptive reactive capacities of the filter. The sensor design will be challenged against an array of ...
SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense -
In vitro Models Suitable for High-throughput Screening of Drug Toxicities in Human Tissues
SBC: Nico Technologies Corp. Topic: CBD10103The drug R&D cycle is long and very expensive. In many ways, this status quo can no longer be sustained. One of the reasons for such great cost is that the vast majority of drug candidates are screened out at the stages of animal and human trials. More efficient methods of testing of drugs at the stage of ex-vivo studies, which are substantially less expensive than animal and human testing cyc ...
SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense